Skip to content
Kalpvruksh Markets
Offline Log in

LUPINNSEOffline

LUPIN · INE326A01037 · Mid Cap · #105
1,988.00−20.60 (−1.03%)last close · 05 Nov 2026
Prev close
2,008.60
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹1,03,625 cr
52-week range · to 05 Nov 20261,9222,514.8

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

LUPIN is 21% below its 52-week high, below its 200-day average, behind Healthcare by 17.5 pts over 3 months — a Mid Cap company, #105 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20-day average · below its 50 / 200-day averages · 21% below its 52-week high
  • behind its industry by 17.5 pts over 3 months · rank 43 of 44 in Healthcare · −14.9% vs Nifty 500
  • traded value 1.4× usual · delivery 53% vs 58% usual
  • short build-up today · IV 23%, 55th pct of its year · expected move ±5.2% to expiry
  • FPI +0.9 pp · DII −0.9 pp · MF schemes in Sept 2026: 90 bought, 56 cut · no promoter pledge · quarter ended 2026-09-30
  • Jun 2026 quarter: profit +16% year on year · revenue +32%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹1,03,625 cr
Rank
#105
Cap band
Mid Cap
Nearest cut-off — Large / Mid
−2.62% from ₹1,06,417 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.1×
median 4,56,264
Delivered
5,06,060
Of volume
44%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week−0.1%−5.6 pts—
1 month−2.0%−6.3 pts−5.7 pts
3 months−16.8%−14.9 pts−17.5 pts
6 months−18.6%−18.9 pts−26.6 pts
1 year+2.2%+4.9 pts—

Industry: Healthcare (Nifty 500 classification) · rank 43 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+1.1%
above
vs 50-day average
−2.8%
below
vs 200-day average
−11.2%
below
ATR (14)
2.2%
typical daily range
Volatility
21%
1 month, annualised
Beta
0.50
vs Nifty 500, 1 year
Traded value
1.4×
vs usual
Delivery
53%
usual 58%
From the 52-week high
−20.9%
place in range 11% (0 = at the low)

F&O

Where option open interest clusters

expiry 23 Nov 2026 · 18 days

Spot
1,988
Max pain
2,000
+0.6% from spot
Largest call OI (strike)
Largest put OI (strike)

Near expiry. Max pain is the strike at which option buyers’ total payout would be least; strikes with the most open interest are where positions cluster.

Volatility & expected move

ATM IV
23.4%
near expiry
IV 30
23.4%
IV rank
43
0–100 within its year
IV percentile
55
days in the year below today
Expected move to expiry
±103.21
±5.2% · one standard deviation
Range
1,885 – 2,091
Rollover
4%
futures OI in next expiries

Futures build-up, by day

all expiries' OI · today: short build-up

SessionBuild-upFuture priceOI, all expiries
05 Nov 2026short build-up−1.6%+1.2%
04 Nov 2026short covering+0.4%−2.1%
03 Nov 2026long build-up+0.6%+0.2%
02 Nov 2026short build-up−0.4%+4.6%
30 Oct 2026short covering+0.9%−2.3%
29 Oct 2026short covering+0.9%−1.1%
28 Oct 2026long build-up+1.2%+1.4%
27 Oct 2026long build-up+0.1%+0.1%
26 Oct 2026short covering+1.2%−0.8%
23 Oct 2026long unwinding−0.1%−2.2%

From the exchanges’ F&O bhavcopies. A description of positions, not a forecast. Open interest across the market.

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters46.9%46.9%46.9%46.8%
FPI21.5%21.7% +0.222.4% +0.723.3% +0.9
Mutual funds18.0%16.9% −1.114.8% −2.114.6% −0.3
Other DII7.6%8.4% +0.89.8% +1.49.2% −0.6
Individuals5.1%5.1%5.1%5.1% +0.1
Others0.9%1.1% +0.11.0%1.0% −0.1

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
2,97,301
Individuals
2,81,831

Indian passive funds’ stake

2026-06-30

Of free float
1.26%
Of all shares
0.67%
Schemes
104
Days to unwind
3.9
at 100% of volume

30,57,454 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
236
104 index · 132 active
Bought more
100
Sold some
82
2 closing out
FundSharesChangeDid
Baroda BNP Paribas Balanced Advantage Fund-Reg(G)Active+2,13,950+1936.2%bought
PGIM India Midcap Fund-Reg(G)Active+2,19,707+1830.9%bought
Capitalmind Flexi Cap Fund-Reg(G)Active+25,477+125.6%bought
HDFC Equity Savings Fund(G)Active−1,48,725−99.2%closing out
Sundaram Dynamic Asset Allocation Fund(G)Active−48,715−98.3%closing out
Canara Rob Large and Mid Cap Fund-Reg(G)Active−5,51,435−89.2%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 262071377497−0.5%₹12,312 cr
Aug 2620126982224−1.3%₹13,343 cr
Jul 2619921596116−3.1%₹14,921 cr
Jun 2619417654125−1.8%₹15,416 cr
May 2620216665322−7.2%₹14,724 cr
Apr 2620817804115−3.9%₹16,137 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Lupin Limited has submitted to the Exchange, the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2026.
    04 Nov 2026
  • Board outcome
    Lupin Limited has submitted to the Exchange, Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.
    07 Aug 2026
  • Scheme / acquisition
    Lupin Limited has informed the Exchange about Lupin Inc. U.S.A., wholly owned subsidiary of the Company has entered into a licensing agreement in exchange of 332,000 Common Shares of Kaveri Therapeutics, Inc. U.S.A.
    21 Jul 2026

LUPIN: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹18Final17 Jul 202617 Jul 2026
EarlierDividend₹12Final25 Jul 202525 Jul 2025
EarlierDividend₹8Final16 Jul 202416 Jul 2024
EarlierDividend₹4Final14 Jul 202314 Jul 2023
EarlierDividend₹4Final14 Jul 202215 Jul 2022
EarlierBonus1:1—11 Aug 200614 Aug 2006

6 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.